Literature DB >> 22309336

Successful treatment of a severe persistent case of pemphigoid gestationis with antepartum and postpartum intravenous immunoglobulin followed by azathioprine.

Desmond Chia Chin Gan1, Belinda Welsh, Michael Webster.   

Abstract

We report a case of pemphigoid gestationis affecting a 37-year-old woman in both her pregnancies. In her second pregnancy she failed to respond to high-dose oral prednisolone. She was treated successfully with intravenous immunoglobulin (2 g/kg each infusion cycle) as a steroid-sparing agent during both the antepartum and postpartum period. The baby was born at the 36th week of gestation. No complications were noted for either mother or baby. After ceasing intravenous immunoglobulin, azathioprine (up to a dose of 1 mg/kg/day) was used to adequately control her pemphigoid gestationis.
© 2012 The Authors. Australasian Journal of Dermatology © 2012 The Australasian College of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22309336     DOI: 10.1111/j.1440-0960.2011.00854.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  2 in total

1.  Pemphigoid gestationis and intravenous immunoglobulin therapy.

Authors:  Anes Yang; Elizabeth Uhlenhake; Dedee F Murrell
Journal:  Int J Womens Dermatol       Date:  2018-05-03

Review 2.  Gestational pemphigoid.

Authors:  Laura Huilaja; Kaarin Mäkikallio; Kaisa Tasanen
Journal:  Orphanet J Rare Dis       Date:  2014-09-02       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.